American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead: Memory function in patients with opioid dependence treated with buprenorphine and methadone in comparison with healthy persons

Lead: Memory function in patients with opioid dependence treated with buprenorphine and methadone in comparison with healthy persons

Monday 2nd June 2025

Explore memory performance in opioid-dependent patients on methadone and buprenorphine vs healthy controls.
7 minutes
Informative
Educational
Engaging
Hopeful
Supportive

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Memory and Opioid Treatment: Surprising Findings

Episode Overview

  • Methadone patients showed better scores in personal information than healthy controls.
  • Buprenorphine treatment linked to improved overall memory scores over time.
  • Caregiver alcohol use significantly increases risk of child maltreatment.
  • Presence of bystanders during overdoses can improve outcomes.
  • Financial stress during COVID-19 pandemic linked to increased alcohol use.
"Longer buprenorphine treatment was linked to better overall memory scores",
Dive into the intricate world of memory function as it relates to opioid dependence treatment in this episode of 'This Week in Addiction Medicine'. The podcast explores a fascinating study comparing memory performance in patients treated with buprenorphine and methadone against healthy individuals. You'll learn how methadone patients surprisingly scored higher than healthy controls in personal and general information, while buprenorphine patients struggled with associate learning.
Interestingly, longer buprenorphine treatment seems to enhance overall memory scores, suggesting its potential benefits over time. Methadone users on long-term treatment showed improved awareness of place and time. Despite these differences, neither medication caused significant negative impacts on memory, except for mental control, which was impaired in both groups. This episode doesn't stop there; it also delves into caregiver alcohol use and its correlation with child maltreatment, revealing some alarming statistics and highlighting the need for stronger preventive measures.
Additionally, the podcast touches on the crucial role of bystanders during overdose deaths in Tennessee, emphasising the importance of naloxone availability. Whether you're intrigued by the complexities of addiction medicine or seeking insights into how treatments can affect cognitive functions, this episode offers valuable knowledge wrapped in engaging discussions. Don't miss out on this enlightening journey through the latest research in addiction medicine.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.